Is It Time To Reassess Madrigal Pharmaceuticals (MDGL) After Its Strong Five Year Share Price Gain
- If you are trying to figure out whether Madrigal Pharmaceuticals is priced attractively today, the starting point is understanding what the current share price really reflects.
- The stock most recently closed at US$513.72, with returns of 0.3% over 7 days, a 6.1% decline over 30 days, a 13.5% decline year to date, a 62.8% return over 1 year, a 67.7% return over 3 years, and a very large 5 year gain of 293.9%.
- These mixed short term and longer term moves have kept Madrigal on the radar of investors weighing both the price and the underlying business story. Recent coverage has focused on how the share price history and fundamentals line up, which provides context for thinking about what you are actually paying for today.
- On Simply Wall…
Source link
